Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Prostate Cancer Version 1.2015. NCCN. Accessed November 4, 2014. Cohen, 2008, Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: The Lahey Clinic Medical Center experience and an international meta-analysis, Eur Urol, 54, 371, 10.1016/j.eururo.2008.03.049 Walz, 2006, High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series, Eur Urol, 50, 498, 10.1016/j.eururo.2006.03.026 Hadaschik, 2011, A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion, J Urol, 186, 2214, 10.1016/j.juro.2011.07.102 Natarajan, 2011, Clinical application of a 3D ultrasound-guided prostate biopsy system, Urol Oncol, 29, 334, 10.1016/j.urolonc.2011.02.014 Sonn, 2014, Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen, Eur Urol, 65, 809, 10.1016/j.eururo.2013.03.025 Sonn, 2013, Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device, J Urol, 189, 86, 10.1016/j.juro.2012.08.095 Pinto, 2011, Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging, J Urol, 186, 1281, 10.1016/j.juro.2011.05.078 Taira, 2010, Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting, Prostate Cancer Prostatic Dis, 13, 71, 10.1038/pcan.2009.42 Zaytoun, 2011, Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population, J Urol, 186, 850, 10.1016/j.juro.2011.04.069 Hambrock, 2010, Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen, J Urol, 183, 520, 10.1016/j.juro.2009.10.022 Vargas, 2012, Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer, J Urol, 188, 1732, 10.1016/j.juro.2012.07.024 Margel, 2012, Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: A prospective cohort study, J Urol, 187, 1247, 10.1016/j.juro.2011.11.112 Stamatakis, 2013, Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer, Cancer, 119, 3359, 10.1002/cncr.28216 Hu, 2014, Targeted prostate biopsy to select men for active surveillance: Do the Epstein criteria still apply?, J Urol, 192, 385, 10.1016/j.juro.2014.02.005 Le, 2014, Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology, J Urol, 192, 1367, 10.1016/j.juro.2014.04.094 Park, 2008, Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy, Invest Radiol, 43, 789, 10.1097/RLI.0b013e318183725e Hara, 2005, Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer, Prostate, 62, 140, 10.1002/pros.20124 Stephenson, 2014, Screening and detection advances in magnetic resonance image-guided prostate biopsy, Urol Clin North Am, 41, 315, 10.1016/j.ucl.2014.01.007 Moore, 2013, Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: Recommendations from an International Working Group, Eur Urol, 64, 544, 10.1016/j.eururo.2013.03.030 Schoots IG, Roobol MJ, Nieboer D, et al. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: A systematic review and meta-analysis [e-pub ahead of print]. Eur Urol. doi:10.1016/j.eururo.2014.11.037, accessed April 23, 2015. Zumsteg, 2012, Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: The standard of care?, Lancet Oncol, 13, e259, 10.1016/S1470-2045(12)70084-0 Klotz, 2015, Long-term follow-up of a large active surveillance cohort of patients with prostate cancer, J Clin Oncol, 33, 272, 10.1200/JCO.2014.55.1192 Hoeks, 2014, Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: A prospective multicenter cohort study, Invest Radiol, 49, 165, 10.1097/RLI.0000000000000008 Panebianco, 2015, Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: A randomized study, Urol Oncol, 33, 17.e1, 10.1016/j.urolonc.2014.09.013 Dickinson, 2013, Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: Could standardization lead to improved utilization of imaging within the diagnostic pathway?, J Magn Reson Imaging, 37, 48, 10.1002/jmri.23689 Barentsz, 2012, ESUR prostate MR guidelines 2012, Eur Radiol, 22, 746, 10.1007/s00330-011-2377-y Hamoen, 2015, Use of the Prostate Imaging Reporting and Data System (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: A diagnostic meta-analysis, Eur Urol, 67, 1112, 10.1016/j.eururo.2014.10.033 Han, 2012, Geometric evaluation of systematic transrectal ultrasound guided prostate biopsy, J Urol, 188, 2404, 10.1016/j.juro.2012.07.107